141 related articles for article (PubMed ID: 31534732)
1. Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long-acting activated memory cells induced by nivolumab against malignant melanoma.
Katagiri K; Shiga K; Saito D; Oikawa SI; Ikeda A; Tsuchida K; Miyaguchi J
Clin Case Rep; 2019 Sep; 7(9):1709-1713. PubMed ID: 31534732
[TBL] [Abstract][Full Text] [Related]
2. Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
Kiyohara Y; Yoshikawa S; Otsuka M; Kondou R; Iizuka A; Nonomura C; Ohshima K; Urakami K; Kusuhara M; Nagashima T; Sugino T; Yamaguchi K; Akiyama Y
J Dermatol; 2017 Oct; 44(10):1156-1159. PubMed ID: 28452169
[TBL] [Abstract][Full Text] [Related]
3. Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Yamaguchi K; Mishima K; Ohmura H; Hanamura F; Ito M; Nakano M; Tsuchihashi K; Ota SI; Wada N; Uchi H; Ariyama H; Kusaba H; Niiro H; Akashi K; Baba E
Cancer Sci; 2018 Oct; 109(10):3032-3042. PubMed ID: 30066977
[TBL] [Abstract][Full Text] [Related]
4. High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.
Koyama N; Iwase O; Nakashima E; Kishida K; Kondo T; Watanabe Y; Takahashi H; Umebayashi Y; Ogawa Y; Miura H
BMC Pulm Med; 2018 Jan; 18(1):23. PubMed ID: 29378571
[TBL] [Abstract][Full Text] [Related]
5. A first reported case of metastatic anorectal amelanotic melanoma with a marked response to anti-PD-1 antibody nivolumab: A case report.
Tokuhara K; Nakatani K; Tanimura H; Yoshioka K; Kiyohara T; Kon M
Int J Surg Case Rep; 2017; 31():188-192. PubMed ID: 28171845
[TBL] [Abstract][Full Text] [Related]
6. Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
Bottlaender L; Breton AL; de Laforcade L; Dijoud F; Thomas L; Dalle S
J Immunother Cancer; 2017 Jul; 5(1):57. PubMed ID: 28716106
[TBL] [Abstract][Full Text] [Related]
7. A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus.
Hanada K; Tsunoda S; Nomura M; Fujimura S; Yutaka Y; Nishigori T; Hisamori S; Maekewa H; Hoshino N; Itami A; Tanaka E; Obama K
Surg Case Rep; 2022 Nov; 8(1):206. PubMed ID: 36333558
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Benefits of Ipilimumab among Japanese Patients with Nivolumab-Refractory Mucosal Melanoma: A Case Series Study.
Saijo K; Imai H; Ouchi K; Okada Y; Sato Y; Komine K; Takahashi M; Takahashi S; Shirota H; Takahashi M; Ishioka C
Tohoku J Exp Med; 2019 May; 248(1):37-43. PubMed ID: 31105123
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of interferon-beta and nivolumab in oral mucosal melanoma.
Fusumae T; Kamiya K; Chiang B; Okada H; Nakano N; Maekawa T; Komine M; Murata S; Ohtsuki M
J Dermatol; 2018 Jan; 45(1):87-90. PubMed ID: 28944501
[TBL] [Abstract][Full Text] [Related]
10. Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.
Baba T; Sakai F; Kato T; Kusumoto M; Kenmotsu H; Sugiura H; Tominaga J; Oikado K; Sata M; Endo M; Yanagawa N; Sasaki S; Iwasawa T; Saito Y; Fujiwara Y; Ohe Y; Yamazaki N; Sakamoto T; Koshiba T; Kuwano K
Future Oncol; 2019 Jun; 15(16):1911-1920. PubMed ID: 31020849
[No Abstract] [Full Text] [Related]
11. Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report.
Lepir T; Zaghouani M; Roche SP; Li YY; Suarez M; Irias MJ; Savaraj N
Medicine (Baltimore); 2019 Jan; 98(2):e13804. PubMed ID: 30633154
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab induced pulmonary sarcoid-like granulomas with a concurrent pleural schwannoma: A pathologic-radiologic correlation of a rare condition mimicking metastatic melanoma.
Jain PV; Squires C; Gasparri M; Sheinin Y
Ann Diagn Pathol; 2022 Apr; 57():151880. PubMed ID: 34972037
[TBL] [Abstract][Full Text] [Related]
13. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report.
Okamoto T; Nakano E; Yamauchi T
J Med Case Rep; 2021 Jul; 15(1):345. PubMed ID: 34256852
[TBL] [Abstract][Full Text] [Related]
14. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma.
Navarro-Fernandez I; Gonzalez-Vela C; Gomez-Fernandez C; Duran-Vian C; Reguero L; Gonzalez-Lopez M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):54-55. PubMed ID: 34477066
[TBL] [Abstract][Full Text] [Related]
15. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
16. Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma.
Nakamura K; Ashida A; Kiniwa Y; Okuyama R
Arch Dermatol Res; 2022 Nov; 314(9):887-895. PubMed ID: 34842960
[TBL] [Abstract][Full Text] [Related]
17. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.
Inadomi K; Kumagai H; Arita S; Tsuruta N; Takayoshi K; Mishima K; Ota SI; Tanaka M; Okumura Y; Sagara K; Nio K; Nakano M; Uchi H; Yamamoto H; Ariyama H; Kusaba H; Niiro H; Oda Y; Akashi K; Baba E
Medicine (Baltimore); 2016 Jul; 95(29):e4283. PubMed ID: 27442668
[TBL] [Abstract][Full Text] [Related]
18. Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma.
Ikeda T; Yamaguchi H; Dotsu Y; Taniguchi H; Gyoutoku H; Senju H; Sakamoto N; Iwanaga S; Kuwatsuka Y; Fukuda M; Mukae H
Thorac Cancer; 2018 Nov; 9(11):1522-1524. PubMed ID: 30253076
[TBL] [Abstract][Full Text] [Related]
19. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients.
De Luca R; Meraviglia S; Blasi L; Maiorana A; Cicero G
Curr Oncol; 2020 Apr; 27(2):e75-e80. PubMed ID: 32489255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]